Literature DB >> 20933019

The effects of pentylenetetrazol, chlordiazepoxide and caffeine in rats tested in the elevated plus-maze depend on the experimental illumination.

Andrea Milena Becerra Garcia1, Fernando P Cardenas, Silvio Morato.   

Abstract

The so-called anxiolytic and anxiogenic drugs are considered to cause, respectively, increases and decreases in plus-maze open arm exploration, without modifying locomotor activity occurring in the closed arms in an elevated plus-maze when the animals are tested in an illuminated environment. Simply testing animals in the dark also increases open arm exploration, which may be interpreted as an anxiolytic effect. We investigated the effects of two GABAergic drugs, pentylenetetrazol (10 and 20 mg/kg) and chlordiazepoxide (1.5 and 3 mg/kg), and one non-GABAergic drug, caffeine (10 and 30 mg/kg) on anxiety levels of rats tested in the elevated plus-maze under two illumination conditions, light or dark. All animals explored more the open arms in the dark. In the light, pentylenetetrazol decreased open arm exploration while chlordiazepoxide had the opposite effect. Neither pentylenetetrazol nor chlordiazepoxide had any effect in the dark. Caffeine, increased open arms exploration in both illumination conditions. These results indicate that light triggers aversion, a response mediated by GABA since the GABAergic drugs, but not caffeine, were ineffective when the rats were tested in the dark.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20933019     DOI: 10.1016/j.bbr.2010.09.032

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  8 in total

1.  Adenosine through the A2A adenosine receptor increases IL-1β in the brain contributing to anxiety.

Authors:  Gabriel S Chiu; Patrick T Darmody; John P Walsh; Morgan L Moon; Kristin A Kwakwa; Julie K Bray; Robert H McCusker; Gregory G Freund
Journal:  Brain Behav Immun       Date:  2014-06-04       Impact factor: 7.217

2.  Effect of histamine H1 and H2 receptor antagonists, microinjected into cerebellar vermis, on emotional memory consolidation in mice.

Authors:  A C L Gianlorenço; K R Serafim; A Canto-de-Souza; R Mattioli
Journal:  Braz J Med Biol Res       Date:  2014-01-17       Impact factor: 2.590

3.  A Methodological Discussion of Caffeine Research and Animal Avoidance Behavior.

Authors:  Abigail E Kennedy; L Michelle Grimes; Rachel S Labaton; Jeffrey F Hine; William J Warzak
Journal:  J Caffeine Res       Date:  2015-12-01

4.  Caffeine and Modafinil Ameliorate the Neuroinflammation and Anxious Behavior in Rats during Sleep Deprivation by Inhibiting the Microglia Activation.

Authors:  Meetu Wadhwa; Garima Chauhan; Koustav Roy; Surajit Sahu; Satyanarayan Deep; Vishal Jain; Krishna Kishore; Koushik Ray; Lalan Thakur; Usha Panjwani
Journal:  Front Cell Neurosci       Date:  2018-02-28       Impact factor: 5.505

5.  Under or Absent Reporting of Light Stimuli in Testing of Anxiety-Like Behaviors in Rodents: The Need for Standardization.

Authors:  Lorenz S Neuwirth; Michael T Verrengia; Zachary I Harikinish-Murrary; Jessica E Orens; Oscar E Lopez
Journal:  Front Mol Neurosci       Date:  2022-08-17       Impact factor: 6.261

6.  Changes in saccharin preference behavior as a primary outcome to evaluate pain and analgesia in acetic acid-induced visceral pain in mice.

Authors:  Beatriz de la Puente; Elizabeth Romero-Alejo; José Miguel Vela; Manuel Merlos; Daniel Zamanillo; Enrique Portillo-Salido
Journal:  J Pain Res       Date:  2015-10-06       Impact factor: 3.133

7.  Effects of caffeine or RX821002 in rats with a neonatal ventral hippocampal lesion.

Authors:  Guy Sandner; Marie-Josée Angst; Thierry Guiberteau; Blandine Guignard; Astrid Nehlig
Journal:  Front Behav Neurosci       Date:  2014-01-28       Impact factor: 3.558

8.  H₁ but not H₂ histamine antagonist receptors mediate anxiety-related behaviors and emotional memory deficit in mice subjected to elevated plus-maze testing.

Authors:  K R Serafim; M S Kishi; A Canto-de-Souza; R Mattioli
Journal:  Braz J Med Biol Res       Date:  2013-04-19       Impact factor: 2.590

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.